BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35345415)

  • 1. 3D-QSAR, ADME-Tox, and molecular docking of semisynthetic triterpene derivatives as antibacterial and insecticide agents.
    Daoui O; Mazoir N; Bakhouch M; Salah M; Benharref A; Gonzalez-Coloma A; Elkhattabi S; Yazidi ME; Chtita S
    Struct Chem; 2022; 33(4):1063-1084. PubMed ID: 35345415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling study of pyrrolidine derivatives as novel myeloid cell leukemia-1 inhibitors through combined 3D-QSAR, molecular docking, ADME/Tox and MD simulation techniques.
    Tabti K; Baammi S; Sbai A; Maghat H; Lakhlifi T; Bouachrine M
    J Biomol Struct Dyn; 2023; 41(23):13798-13814. PubMed ID: 36841617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Modeling Studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques.
    Abdizadeh R; Hadizadeh F; Abdizadeh T
    Med Chem; 2020; 16(7):903-927. PubMed ID: 31385775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing of the N-ethyl-4-(pyridin-4-yl)benzamide based potent ROCK1 inhibitors using docking, molecular dynamics, and 3D-QSAR.
    Ghosh S; Keretsu S; Cho SJ
    PeerJ; 2021; 9():e11951. PubMed ID: 34434664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
    Gajjar KA; Gajjar AK
    Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors.
    Dowlati Beirami A; Hajimahdi Z; Zarghi A
    J Biomol Struct Dyn; 2019 Jul; 37(11):2999-3006. PubMed ID: 30035675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico research on new sulfonamide derivatives as BRD4 inhibitors targeting acute myeloid leukemia using various computational techniques including 3D-QSAR, HQSAR, molecular docking, ADME/Tox, and molecular dynamics.
    Belghalia E; Ouabane M; El Bahi S; Rehman HM; Sbai A; Lakhlifi T; Bouachrine M
    J Biomol Struct Dyn; 2023 Sep; ():1-19. PubMed ID: 37656159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D QSAR pharmacophore, CoMFA and CoMSIA based design and docking studies on phenyl alkyl ketones as inhibitors of phosphodiesterase 4.
    Gaurav A; Singh R
    Med Chem; 2012 Sep; 8(5):894-912. PubMed ID: 22741782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D-QSAR Studies, Molecular Docking, Molecular Dynamic Simulation, and ADMET Proprieties of Novel Pteridinone Derivatives as PLK1 Inhibitors for the Treatment of Prostate Cancer.
    Er-Rajy M; El Fadili M; Imtara H; Saeed A; Ur Rehman A; Zarougui S; Abdullah SA; Alahdab A; Parvez MK; Elhallaoui M
    Life (Basel); 2023 Jan; 13(1):. PubMed ID: 36676076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.
    Patel PD; Patel MR; Kaushik-Basu N; Talele TT
    J Chem Inf Model; 2008 Jan; 48(1):42-55. PubMed ID: 18076152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved 3D-QSAR Prediction by Multiple Conformational Alignments and Molecular Docking Studies to Design and Discover HIV-I Protease Inhibitors.
    Patel PK; Bhatt HG
    Curr HIV Res; 2021; 19(2):154-171. PubMed ID: 33213349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
    Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG
    Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A computer-aided drug design approach to explore novel type II inhibitors of c-Met receptor tyrosine kinase for cancer therapy: QSAR, molecular docking, ADMET and molecular dynamics simulations.
    Daoui O; Nour H; Abchir O; Elkhattabi S; Bakhouch M; Chtita S
    J Biomol Struct Dyn; 2023; 41(16):7768-7785. PubMed ID: 36120976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D-QSAR, molecular docking, and molecular dynamics simulation study of thieno[3,2-
    Xu Y; He Z; Liu H; Chen Y; Gao Y; Zhang S; Wang M; Lu X; Wang C; Zhao Z; Liu Y; Zhao J; Yu Y; Yang M
    RSC Adv; 2020 Feb; 10(12):6927-6943. PubMed ID: 35493862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking.
    Jian Y; He Y; Yang J; Han W; Zhai X; Zhao Y; Li Y
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of tricyclic piperazine/piperidine furnished molecules as novel integrin αvβ3/αIIbβ3 dual antagonists using 3D-QSAR and molecular docking.
    Yan Y; Li Y; Zhang S; Ai C
    J Mol Graph Model; 2011 Feb; 29(5):747-62. PubMed ID: 21273104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation and 3D-QSAR studies of imidazolidine-2,4-dione derivatives as novel protein tyrosine phosphatase 1B inhibitors.
    Wang MY; Jin YY; Wei HY; Zhang LS; Sun SX; Chen XB; Dong WL; Xu WR; Cheng XC; Wang RL
    Eur J Med Chem; 2015 Oct; 103():91-104. PubMed ID: 26342135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined 3D-QSAR modeling and molecular docking study on quinoline derivatives as inhibitors of P-selectin.
    Zeng H; Cao R; Zhang H
    Chem Biol Drug Des; 2009 Dec; 74(6):596-610. PubMed ID: 19843078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking.
    Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of novel amyloid β aggregation inhibitors using QSAR, pharmacophore modeling, molecular docking and ADME prediction.
    Aswathy L; Jisha RS; Masand VH; Gajbhiye JM; Shibi IG
    In Silico Pharmacol; 2018; 6(1):12. PubMed ID: 30607325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.